Liyun Fu

1.8k total citations
28 papers, 1.4k citations indexed

About

Liyun Fu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Liyun Fu has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Liyun Fu's work include Circular RNAs in diseases (15 papers), MicroRNA in disease regulation (14 papers) and Cancer-related molecular mechanisms research (10 papers). Liyun Fu is often cited by papers focused on Circular RNAs in diseases (15 papers), MicroRNA in disease regulation (14 papers) and Cancer-related molecular mechanisms research (10 papers). Liyun Fu collaborates with scholars based in China, United States and Hong Kong. Liyun Fu's co-authors include Junming Guo, Tianwen Li, Yaoren Hu, Bingxiu Xiao, Ting Yao, Qingqing Chen, Xiaoyan Mo, Linwen Zhu, Yi Xie and Yongfu Shao and has published in prestigious journals such as Gut, Gene and Life Sciences.

In The Last Decade

Liyun Fu

28 papers receiving 1.4k citations

Peers

Liyun Fu
Comparison fields: 5 of 83
  • Molecular Biology 1.2k
  • Cancer Research 1.1k
  • Epidemiology 98
  • Oncology 77
  • Hepatology 74
Replace Laura Santangelo with:
Laura Santangelo Italy
Yan Xie China
Yongliang Yao China
Yun-Le Wan China
Xu Song China
Yanping Yu United States
Hongxia Li China
Yiquan Xue China
Nianli Liu China
Zhigao Xu China
Laura Santangelo Italy View profile →
Citations per field, relative to Liyun Fu
Liyun Fu · 1×
Citations per year, relative to Liyun Fu
Liyun Fu · 1×

Countries citing papers authored by Liyun Fu

Since Specialization
Citations

This map shows the geographic impact of Liyun Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyun Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyun Fu more than expected).

Fields of papers citing papers by Liyun Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyun Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyun Fu. The network helps show where Liyun Fu may publish in the future.

Co-authorship network of co-authors of Liyun Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Liyun Fu. A scholar is included among the top collaborators of Liyun Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyun Fu. Liyun Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 4
2 3
3 6
4 10
5 18
6 48
7 31
8 1
9 23
10 31
11 31
12 32
13 228
14 64
15 93
16 19
17 50
18 35
19 57
20
[Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR].
16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026